The following FAQ (Frequently Asked Questions) consist of recurring questions to IFA GmbH. They are grouped under a topic and followed by their answer. If your question is not mentioned, please do not hesitate to contact us directly.
Following the Framework Agreement according to Section 131 SGB V (German Social Code Book V), this information is compulsory for medicianal products for human use.
The allocation of the product-specific address data to the PZN is usually conducted when ordering the first publication in the IFA information services of new prescription drugs and non-prescription drugs relevant for reimbursement.
Please use the following documents and enter the address data for each PZN (address number or company name of the authorisation holder / local representative):
IFA-Auftragstabelle B1 – First Publication Medicinal Product or
Anlage B1 – PZN First Publication Medicinal Product
If you do not know the address number of the marketing authorisation holder or local representative, please notify the relevant address with the following documents:
IFA-Auftragstabelle D2 – Product-related Address Data or
Anlage D2 – Product-related Address Data
There are two options for the notification of product-specific address data:
Please order a product range data file and fill in the address data (address number or company name of the marketing authorisation holder / local representative) and send it conclusively by e-mail to email@example.com.
Please send us an individually created table specifying the PZN and the corresponding address data by e-mail to firstname.lastname@example.org (address number or company name of the marketing authorisation holder / local representative) with the following column headers:
PZN | Address-No. MAH | MAH | Address-No. local representative | Local representative
No, for the notification of product-specific address data EAD files cannot be used.